BD ProEx C: A sensitive and specific marker of HPV-associated squamous lesions of the cervix

American Journal of Surgical Pathology

Volumn 32, Issue 6, 2008, Pages 899-906

  Badr, Riem E ^a   Walts, Ann E ^a   Chung, Fai ^a   Bose, Shikha ^a,b  

^a Cedars Sinai Medical Center   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

cervical intraepithelial neoplasia; human papilloma virus; Ki67; p16; ProEx C

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) ALPHA; KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 2; PROTEIN P16; UNCLASSIFIED DRUG; VIRUS DNA; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; DNA TOPOISOMERASE II ALPHA; MCM2 PROTEIN, HUMAN; NUCLEAR PROTEIN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PRECANCER; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NUCLEAR PROTEINS; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 46249119192     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31815bbb69     Document Type: Article

References (25)

1. Burden DA, Froelich-Ammon SJ, Osheroff N. Topoisomerase II-mediated cleavage of plasmid DNA. Methods Mol Biol. 2001;95: 283-289.
2. Chen Y, Miller C, Mosher R, et al. Identification of cervical cancer markers by cDNA and tissue microarrays. Cancer Res. 2003;63: 1927-1935.
3. Dyson N, Howley PM, Munger K, et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243:934-937.
4. Hu L, Guo M, He Z, et al. Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents. Mod Pathol. 2005;18:267-273.
5. Ismail SM, Colclough AB, Dinnen JS, et al. Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. BMJ. 1989;298:707-710.
6. Ismail SM, Colclough AB, Dinnen JS, et al. Reporting cervical intra-epithelial neoplasia (CIN): intra- and interpathologist variation and factors associated with disagreement. Histopathology. 1990; 16:371-376.
7. Jones BA, Davey DD. Quality management in gynecologic cytology using interlaboratory comparison. Arch Pathol Lab Med. 2000;124: 672-681.
8. Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol. 2001; 25:884-891.
9. Kelly D, Kincaid E, Fansler Z, et al. Detection of cervical highgrade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C). Cancer. 2006;108: 494-500.
10. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001; 92:276-284.
11. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohisto-chemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002;26: 1389-1399.
12. Malinowski DP. Multiple biomarkers in molecular oncology. I. Molecular diagnostics applications in cervical cancer detection. Expert Rev Mol Diagn. 2007;7:117-131.
13. Murphy N, Ring M, Heffron CC, et al. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol. 2005;58:525-534.
14. O'Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol. 2006;13:8-15.
15. Sano T, Masuda N, Oyama T, et al. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int. 2002; 52:375-383.
16. Santin AD, Zhan F, Bignotti E, et al. Gene expression profiles of primary HPV 16- and HPV 18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate biomarkers for cervical cancer diagnosis and therapy. Virology. 2005;331:269-291.
17. Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med. 2003;127:946-949.
18. Schwarz E, Freese UK, Gissmann L, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985;314:111-114.
19. Shi J, Liu H, Wilkerson M, et al. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProE(X) C, and p16INK4a/ProE(X) C in cervical squamous intraepithelial lesions. Hum Pathol. 2007;38:1335-1344.
20. Shroyer KR, Homer P, Heinz D, et al. Validation of a novel immunocytochemical assay for topoisomerase II-alpha and mini-chromosome maintenance protein 2 expression in cervical cytology. Cancer. 2006;108:324-330.
21. Tinker A. Worldwide cervical cancer issues. National Cancer Coalition. [November 2005]. Available at: http://www.nccc-online.org/ worldcancer.php.
22. Walts AE, Bose S. P16/Ki-67 immunostaining is useful in stratification of atypical metaplastic epithelium of the cervix. Modern Path. 2007. In press.
23. Walts AE, Lechago J, Bose S. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia. Am J Surg Pathol. 2006;30:795-801.
24. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990;248:76-79.
25. Zur HH. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342-350.